The EMBO Journal2d
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...
insurancebusinessmag3d
Sedgwick releases first Australian Recall Index report
Sedgwick brand protection has launched the first Australian edition of its Recall Index, which tracks product recalls and regulatory developments across five major industries.
Cybrexa Therapeutics Announces Positive Final Data at ESMO 2024 from Phase 1 Study of Peptide Drug Conjugate CBX-12 in Advanced Solid Tumors
Data demonstrate broad activity of CBX-12 across six tumor types with a strong response rate in TOP1-naïve patients with ovarian (40%; N=10) and ...